Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

July 15, 2021

Study Completion Date

November 15, 2021

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Oxaliplatin, Cetuximab, Bevacizumab, Panitumumab, Irinotecan, Leucovorin, 5-Fluorouracil

Oxaliplatin 100 mg/m² infusion in 2 hours, Cetuximab 500mg/m² infusion in 2 hours, Bevacizumab 5 mg/kg infusion in 30 minutes, Panitumumab 6 mg/kg, Irinotecan 180 mg/m² over 90 minutes to begin 30 minutes after folinic acid infusion is started, Leucovorin 400 mg/m² infusion in 2 hours, 5-Fluorouracil 2400 mg/m² infusion continuous in 46h

Trial Locations (4)

94

Gustave Roussy, Villejuif

Unknown

Ico Paul Papin, Angers

Centre Eugene Marquis, Rennes

Chp Saint Gregoire, Saint-Grégoire

All Listed Sponsors
lead

UNICANCER

OTHER

NCT03164655 - Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network | Biotech Hunter | Biotech Hunter